{'fraction_non_alphanumeric': 0.018077239112571898, 'fraction_numerical': 0.011503697617091208, 'mean_word_length': 5.151515151515151, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Face transplantation: a medical perspective.

In May 2004, researchers at the University of Louisville Medical Center in Kentucky submitted a 30-page detailed document to the University's Institutional Review Board (IRB) that outlines their plan for the first face transplant. Despite the fact that both the Royal College of Surgeons in England in 2003 and France's Comite Consultatif National d'Ethique in 2004 issued reports saying that the risks of this surgery far outweigh the benefits to justify it at the present time, the IRB at the University of Louisville is presently studying the proposal. These medical professionals believe they have the microsurgical skills and the anatomical knowledge needed to perform this surgery as well as the pharmaceutical recipe needed to suppress the immune system while ensuring tolerable levels of toxicity in the patient. However, with the number of serious unknowns about this surgery, the risk of further injury and even death to the recipients, and the viable option of reconstructive surgery, face transplantation, a the present time, is not a just use of medical resources, in the best interest of the patient, or an effective way to accomplish the goals of medicine.